Pandemic influenza A(H1N1)2009: Molecular characterisation and duration of viral shedding in intensive care patients in Bordeaux, south-west France, May 2009 to January 2010

Eurosurveillance

Volumn 16, Issue 4, 2011, Pages

  Malato, L ^a   Llavador, V ^a   Marmier, E ^a   Youssef, J ^a   Weber, C Balick ^a   Roze H ^a   Bessede, E ^a   Fleury, H J ^a  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR; SIALIDASE;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; AGED; ARTICLE; CANDIDA ALBICANS; CHILD; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; ENTEROBACTER CLOACAE; FEMALE; FRANCE; GENE AMPLIFICATION; GENE MUTATION; HAEMOPHILUS INFLUENZAE; HUMAN; INFANT; INTENSIVE CARE; MALE; MIXED INFECTION; MOLECULAR DYNAMICS; MORAXELLA CATARRHALIS; MYCOPLASMA PNEUMONIAE; PANDEMIC INFLUENZA; PRESCHOOL CHILD; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SCHOOL CHILD; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; TREATMENT DURATION; VIRUS SHEDDING; VIRUS VIRULENCE;

EID: 79551590073     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Baz M, Abed Y, Simon P, Hamelin M, Boivin G. Effect of the neuraminidase mutation H274Y conferring resistance to oseltamivir on the replicative capacity and virulence of old and recent human influenza A(H1N1) viruses. J Infect Dis. 2010;201(5):740-5.
2. Antón A, Marcos MA, Martínez MJ, Ramón S, Martínez A, Cardeñosa N, et al. D225G mutation in the hemagglutinin protein found in 3 severe cases of 2009 pandemic influenza A (H1N1) in Spain. DiagnMicrobiol Infect Dis. 2010;67(2):207-8.
3. Glinsky GV. Genomic analysis of pandemic (H1N1) 2009 reveals association of increasing disease severity with emergence of novel hemagglutinin mutations. Cell Cycle. 2010;9(5):958-70.
4. Liu Y, Childs RA, Matrosovich T, Wharton S, Palma AS, Chai W, et al. Altered receptor specificity and cell tropism of D222G hemagglutinin mutants isolated from fatal cases of pandemic A(H1N1) 2009 influenza virus. J Virol. 2010;84(22):12069-74.
5. Mak GC, Au KW, Tai LS, Chuang KC, Cheng KC, Shiu TC, et al. Association of D222G substitution in haemagglutinin of 2009 pandemic influenza A (H1N1) with severe disease. Euro Surveill. 2010;15(14):pii=19534. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19534
6. Burrel S, Roncin L, Lafon ME, Fleury H. Oseltamivir susceptibility in south-western France during the 2007-8 and 2008-9 influenza epidemics and the ongoing influenza pandemic 2009. Euro Surveill. 2009;14(38):pii=19334. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19334
7. Fleury H, Burrel S, Balick Weber C, Hadrien R, Blanco P, Cazanave C, et al. Prolonged shedding of influenza A(H1N1) v virus: two case reports from France 2009. Euro Surveill. 2009;14(49):pii=19434. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19434
8. Bilan épidémiologique de la grippe A(H1N1)2009 en Aquitaine, 2009-2010. [Epidemiological assessment of influenza A(H1N1)2009 in Aquitaine, 2009-2010]. Bulletin de veille sanitaire. 2010;5. Paris: Institut de Veille Sanitaire; August 2010. Available from: http://www.invs.sante.fr/publications/bvs/aquitaine/2010/bvs_aquitaine_2 010_05.pdf
9. Chowell G, Bertozzi SM, Colchero MA, Lopez-Gatell H, Alpuche-Aranda C, Hernandez M, et al. Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med. 2009;361(7):674-9.
10. Sullivan SJ, Jacobson RM, Dowdle WR, Poland GA. 2009 H1N1 influenza. Mayo Clin Proc. 2010;85(1):64-76.
11. ANZIC Influenza Investigators, Webb SA, Pettilä V, Seppelt I, Bellomo R, Bailey M, et al. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med. 2009;361(20):1925-34.
12. Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J, et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA. 2009;302(17):1872-9.
13. Rello J, Rodríguez A, Ibañez P, Socias L, Cebrian J, Marques A, et al. Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain. Crit Care. 2009;13(5):R148.
14. Domínguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, de la Torre A, et al. Critically ill patients with 2009 influenza A(H1N1) in Mexico. JAMA. 2009;302(17):1880-7.
15. Davies A, Jones D, Bailey M, Beca J, Bellomo R, Blackwell N, et al. Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA. 2009;302(17):1888-95.
16. Centers for Disease Control and Prevention (CDC).Hospitalized Patients with novel influenza A (H1N1) virus infection - California, April-May, 2009. MMWR Morb Mortal Wkly Rep. 2009;58(19):536-41.
17. Díaz E, Rodríguez A, Martin-Loeches I, Lorente L, Del Mar Martín M, Pozo JC, et al. Impact of obesity in patients infected with new influenza A(H1N1)v. Chest. 2010 Aug 5. [Epub ahead of print].
18. Martín-Loeches I, Sanchez-Corral A, Diaz E, Granada R, Zaragoza R, Villavicencio C, et al. Community-acquired respiratory co-infection (CARC) in critically ill patients infected with pandemic 2009 influenza A (H1N1) virus infection. Chest. 2010 Oct 7. [Epub ahead of print].
19. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009;360(25):2605-15.
20. Cao B, Li X, Mao Y, Wang J, Lu H, Chen Y, et al. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med. 2009;361(26):2507-17.
21. Cowling BJ, Chan KH, Fang VJ, Lau LL, So HC, Fung RO, et al. Comparative epidemiology of pandemic and seasonal influenza A in households. N Engl J Med. 2010;362(23):2175-84.
22. Aoki FY, Macleod MD, Paggiaro P, Carewicz O, El Sawy A, Wat C, et al. Early administration of oral oseltamivir increases the benefits of influenza treatment. J Antimicrob Chemother. 2003;51(1):123-9.
23. Na S, Chong YP, Kim MN, Kim WY, Kim W, Hong SB, et al. Duration of viral shedding in patients admitted to hospital with pandemic influenza A/H1N1 2009 infection. J Med Virol. 2011;83(1):5-9.
24. Ling LM, Chow AL, Lye DC, Tan AS, Krishnan P, Cui L, et al. Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection. Clin Infect Dis. 2010;50(7):963-9.
25. Meijer A, Lackenby A, Hungnes O, Lina B, van-der-Werf S, Schweiger B, et al. Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season. Emerging Infect Dis 2009;15(4):552-60.
26. Hurt AC, Holien JK, Parker MW, Barr IG. Oseltamivir resistance and the H274Y neuraminidase mutation in seasonal, pandemic and highly pathogenic influenza viruses. Drugs. 2009;69(18):2523-31.
27. Abed Y, Goyette N, Boivin G. A reverse genetics study of resistance to neuraminidase inhibitors in an influenza A/H1N1 virus. Antivir Ther. 2004;9(4):577-81.
28. Influenza - update 114. Global Alert and Response (GAR). Geneva: World Health Organisation; 20 August 2010. Available from: http://www.who.int/csr/don/2010_08_20/en/index.html
29. Rogers GN, Daniels RS, Skehel JJ, Wiley DC, Wang XF, Higa HH, et al. Host-mediated selection of influenza virus receptor variants. Sialic acid-alpha 2,6Gal-specific clones of A/duck/ Ukraine/1/63 revert to sialic acid-alpha 2,3Gal-specific wild type in ovo. J Biol Chem. 1985;260(12):7362-7.
30. Tumpey TM, Maines TR, Van Hoeven N, Glaser L, Solórzano A, Pappas C, et al. A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science. 2007;315(5812):655-9.
31. Preliminary review of D222G amino acid substitution in the haemagglutinin of pandemic influenza A (H1N1) 2009 viruses. Wkly Epidemiol Rec. 2010;85(4):21-2.
32. Kilander A, Rykkvin R, Dudman SG, Hungnes O. Observed association between the HA1 mutation D222G in the 2009 pandemic influenza A(H1N1) virus and severe clinical outcome, Norway 2009-2010. Euro Surveill. 2010;15(9):pii=19498. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19498
33. Puzelli S, Facchini M, De Marco MA, Palmieri A, Spagnolo D, Boros S, et al. Molecular surveillance of pandemic influenza A(H1N1) viruses circulating in Italy from May 2009 to February 2010: association between haemagglutinin mutations and clinical outcome. Euro Surveill. 2010;15(43):pii=19696. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19696
34. Maines TR, Jayaraman A, Belser JA, Wadford DA, Pappas C, Zeng H, et al. Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science. 2009 24;325(5939):484-7.
35. Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y. Avian flu: influenza virus receptors in the human airway. Nature. 2006;440(7083):435-6.